• Science & Technology

Unravelling the mystery of Barrett’s oesophagus

Barrett’s oesophagus affects around 1 in every 100 to 200 people in the UK, and, for a small number of people, can develop into oesophageal cancer. But the origins of the condition have remained a mystery for decades, until now. Barrett’s oesophagus affects around 1 in every 100 to 200 people in the UK, and, for a small number of people, can develop into oesophageal cancer. But the origins of the condition have remained a mystery for decades, until now.

25 October 2021

• Health & Medicine

Immunotherapy approved for some people with oesophageal cancer on NHS in England

The immunotherapy drug nivolumab (Opdivo) has been made available for some people in England with oesophageal cancer, in what has been described as a ‘step change’ for people with this cancer. The immunotherapy drug nivolumab (Opdivo) has been made available for some people in England with oesophageal cancer, in what has been described as a ‘step change’ for people with this cancer.

20 October 2021

• For Researchers

The award-winning researcher behind next generation sequencing

We speak to Professor Shankar Balasubramanian about his work on NGS, his incredible translational journey and the power of the pub… We speak to Professor Shankar Balasubramanian about his work on NGS, his incredible translational journey and the power of the pub…

15 October 2021

• For Researchers

Recognising the essential role of clinical research nurses

We hear from Rosie Lomas - the 'Excellence in Cancer Research Nursing Award' winner - and the other shortlisted nurses about their work and the vital role they play in delivering clinical trials. We hear from Rosie Lomas - the 'Excellence in Cancer Research Nursing Award' winner - and the other shortlisted nurses about their work and the vital role they play in delivering clinical trials.

13 October 2021

• For Researchers

Prize winning early detection research

Professor Rebecca Fitzgerald on the power of collaboration, taking risks and the rise of early detection as a hot topic for researchers... Professor Rebecca Fitzgerald on the power of collaboration, taking risks and the rise of early detection as a hot topic for researchers...

7 October 2021

• For Researchers
• Science & Technology

Delivering the future of paediatric brain tumour therapy

Dr Lisa Ruff tells us why drug delivery is so important for the treatment of paediatric brain tumours – and why hydrogels could be key to a breakthrough… Dr Lisa Ruff tells us why drug delivery is so important for the treatment of paediatric brain tumours – and why hydrogels could be key to a breakthrough…

7 October 2021

• Health & Medicine

Cancer in children and young people: how far we’ve come

Since the 1970s, 30,000 deaths have been avoided thanks in part to the progress we’ve made in diagnosing and treating children's and young people's cancers. Since the 1970s, 30,000 deaths have been avoided thanks in part to the progress we’ve made in diagnosing and treating children's and young people's cancers.

29 September 2021

• For Researchers
• Health & Medicine

Making the most of your ‘eureka’ moment: getting from the science to the clinic

How can we make the vital journey from research to clinical impact more efficient? It all comes down to empowering researchers to develop an entrepreneurial mindset How can we make the vital journey from research to clinical impact more efficient? It all comes down to empowering researchers to develop an entrepreneurial mindset

22 September 2021

• For Researchers

A celebration of peer review

As part of Peer Review Week, we are very proud to celebrate the essential role our research community play in this process. Here we chat to Professor Marcus Munafò – a member of one of our funding committees As part of Peer Review Week, we are very proud to celebrate the essential role our research community play in this process. Here we chat to Professor Marcus Munafò – a member of one of our funding committees

21 September 2021

• Science & Technology
• Health & Medicine

Precision drug slows progression of advanced breast cancer

Patients taking the drug trastuzumab deruxecan were 72% less likely to see their cancer grow significantly or to die than those on an existing breast cancer treatment. Patients taking the drug trastuzumab deruxecan were 72% less likely to see their cancer grow significantly or to die than those on an existing breast cancer treatment.

21 September 2021

• For Researchers
• Science & Technology

How cancer hijacks cell death: a new view of metastasis

Professor Jody Rosenblatt tells us why dysregulated cell death could have an impact not only on metastasis, but also therapy resistance. Professor Jody Rosenblatt tells us why dysregulated cell death could have an impact not only on metastasis, but also therapy resistance.

17 September 2021